Futura Medical’s Eroxon has paved the way for the launch of the first commercial gel for erectile dysfunction in the United States, receiving marketing approval from the Food and Drug Administration (FDA), CNN reports. The announcement was made by the pharmaceutical company on Monday. The product has been available in the UK and Belgium for some time and is also licensed in the European Union and parts of the Middle East. Eroxone is a non-medicated hydroalcoholic gel for the treatment of erectile dysfunction in adult men over the age of 22. This approval makes it the first commercially available gel for the treatment of erectile dysfunction. (Also read: Erectile Dysfunction in Men: Causes, Symptoms, Prevention Tips, and Effective Treatments for This Sexual Disorder in Men)
Erectile dysfunction is a common condition affecting millions of men worldwide. According to the WHO, in 1995 he estimated that 150 million men worldwide suffered from erectile dysfunction, and that number is expected to reach 322 million by 2025. is expected to. About 30 million people in the United States alone suffer from erectile dysfunction. Erectile dysfunction is the inability to obtain and maintain an erection strong enough for sex. It can be a sign of both physical or psychological conditions.
how to use gel
CNN reported that the gel comes in a single-dose tube and should be applied to the head of the penis for 15 seconds before intercourse. According to the FDA, upon application, the formulation’s volatile components (alcohol and water) evaporate, producing a rapid, localized cooling effect on the glans penis, followed by a slow restoration of the warming effect. This stimulates nerve endings, leading to swelling and an erection. The product claims to be able to induce an erection within 10 minutes of application. Viagra, on the other hand, takes 30-60 minutes to take effect.
How much is it
A Futura Medical spokesperson said a four-pack of Eroxon costs around £24.99 at the United Nations. This makes him $31.22 in the US. However, a spokesperson said in an email that specific pricing details have yet to be determined, CNN reported.
What Doctors Say About Eroxon
According to Professor David Ralph, Consultant Urologist at University College London and former President of the European Society of Sexual Medicine, the product with topical application is ideal for mild to moderate ED who want rapid onset of action. particularly attractive to patients.
“Eroxone’s efficacy is remarkable, with two Phase 3 trials showing clinically meaningful benefit to most patients with erectile dysfunction, but adverse events are the current first-line Significantly less than therapy.It will be particularly attractive for topical application.”Patients with mild to moderate ED who want rapid onset of action. With no drug interactions with prescription medications, this product can be used with other medications such as nitrates and other cardiovascular medications. As such, the product is of great interest to medical personnel. community,” Professor Ralph said on his Futura Medical website.
